Peter Kolchinsky

Peter Kolchinsky

@peterkolchinsky.bsky.social

Biotech investor. Virologist. Author: The Great American Drug Deal. Founder: No Patient Left Behind. Healthcare reform advocate. Daughter says I’m cool 75% of the time; son says 100%.

785 followers27 following64 posts

Pinned

Peter Kolchinsky reposted

Here, here. "Congress must now also exercise its oversight responsibilities to ensure repairs to FDAs current and future capabilities, infrastructure, human resources, and reputation begin as soon as possible." Big deal coming from investors/companies. www.nopatientleftbehind.org/evidence-bas...

nopatientleftbehind.orgSupporting the Call for Evidence-Based Policy and Public Health Security — No Patient Left Behind

Peter Kolchinsky reposted

Autoimmune diseases afflict 45 million Americans—and it requires a collective community effort to change that. Our new Community Quest video shows how investors, innovators, regulators, patients, insurers—and you—make new treatments possible, accessible, and affordable.

nopatientleftbehind.orgOur Quest to Beat Autoimmune Disorders — No Patient Left BehindBiomedical innovators are developing new autoimmune therapeutics - insurance reform will ensure new treatments and cures are accessible and affordable.

Rfk Jr & vaccine “skeptics” mislead when they say vaccines haven’t been tested vs placebo. The first vaccine of every kind is absolutely tested vs placebo. When it works, it’s unethical to test future versions vs placebo. Those are tested vs prior version. If better, then also better than placebo.

Biotech on Bluesky get a look first. RA Capital’s annual thoughts on how biotech can better (Semper Maior; always better). This one explore how we can elicit more candor. Some stories, too. And tons of top-down data analyzing 2024 performance & setup for 2025. rapport.bio/all-stories/...

rapport.bioSemper Maior: Pumping up the candor — RApportWouldn’t it be better if everyone in our ecosystem were candid with one another? After all, within companies it’s common to encourage everyone to speak their minds. If you see a problem, call it out;...

We’ll soon open up application for the next No Patient Left Behind fellowship. Completing the “Biotech Unveiled” course & earning a certificate (gotta score well) qualifies one to apply for the fellowship. Will likely also be part of applying to our TechAltas division.

The interesting thing about Bluesky is watching something like the Wild West open up. Who knows if it ever becomes as populated as Twitter, but in these early days, you see how a platform takes shape. For example, notice the ratio of followers to posts… it seems a sign of how… 1/4

View full thread

I’m guessing that as the platform matures and people saturate their target market, the ratios won’t be as useful. But for now, Bluesky and many people are it offer a dynamic range in which to appreciate what diffuses through its thick liquid (twitter is more a gas).

The interesting thing about Bluesky is watching something like the Wild West open up. Who knows if it ever becomes as populated as Twitter, but in these early days, you see how a platform takes shape. For example, notice the ratio of followers to posts… it seems a sign of how… 1/4

…interesting someone might be. Some people have a <1 ratio, many are around 10, and some standouts are at 100. I would say this is like a virus’s r (which indicates how infectious it is) except that followers effectively never decline (everyone stays infected :)

As a virologist, I encourage everyone to listen to @scottgottliebmd.bsky.social’s advice on preparing for possible flu pandemic. As an investor, I hope US makes appropriate investments. We have better tools now than we did for COVID. Diff virus, diff tools. www.washingtonpost.com/opinions/202...

washingtonpost.comOpinion | Biden faltered on bird flu. Here’s how Trump can course-correct.The Biden administration’s bird flu response has been too slow. Now comes a test for Trump’s White House.

My whole career (scientist/VC) there were diseases that I thought I might never be cracked. Alzheimer’s was one. Now seeing signs of progress. Lupus was another, now cracking. I think it’s curable. What diseases would you want to see cured? Scientists here can add if they feel optimistic.

What was an investor’s real reason for passing? What do they know? Might that info help a company? Yet, there’s a downside to candor. Feelings may get hurt. Investors get ghosted on deal. How might we flip it so there’s upside? Insights from #biotech & any sector welcome.

And same question for eliciting candid feedback from board members. Little sense in experienced people passively having slides read to them thinking “this isn’t compelling” and not getting to the heart of the problem. How to spark constructor candor? How to remove downsides of being candid?

Think of all the knowledge locked away in people’s heads that isn’t being shared because of the perception that there’s no upside for the giving party or clear downside. This is game theory. A tweak of the rules could lead to a very different outcome. What tweaks could work?

Every Xmas, those of us who are w/ our families appreciate all who work to keep the world running. Store clerks, nurses, police, public utility workers… …and, did you know, in the drug industry, many scientists & technicians keep experiments running & medicines in production. Thank you all :)

View full thread

It comes with a great epilogue that addresses common “but what about!?” questions whenever you suggest that maybe drug companies don’t price gouge. (Eg but Canada pays less!). We also discuss all this in the fellowship. rapport.bio/supplemental...

rapport.bioBut what about … — RApportYou’ve read one of our articles about why the amount we pay for branded drugs while they’re on patent is worth it, or our calls for insurance reform. But you still have some questions. We hope this an...
View full thread

What I’m really saying is that it’s not enough to be good… you have to either know how to convey convincingly to others that you are good or else have others who are convincing be able and willing to vouch for you that you are good. Otherwise, it’s hard to break through the noise.

View full thread

…so I could then apply for a job in business development. Eventually he did, though by then I had other offers. I created that optionality for myself intentionally. Be similarly rational and intentional about cultivating mentors and references.

Be super useful to them. Impress them with your work. If you fail to impress someone, then move on to impressing someone else. Eventually you have to get good enough at something to impress people with what you can do so they can vouch for you.

View full thread

If they are not well connected, then it’s like being useful to a fellow stranded person… now you are both stranded together. When I was starting the Harvard Biotech Club, I recruited the head of Beth Israel’s tech transfer office to be our student group advisor.

He kindly said yes and I then used that opportunity to impress him with how hard I was willing to work to build the club, rally people, and create opportunities for others to learn about biotech. My hope was that he would give me a chance to intern in his tech transfer office…

View full thread

If you don’t get good at capturing someone’s interest with a note about yourself, your accompaniments, and how you could be relevant to them, you may struggle to stand out from the masses of other vague people and will likely need others to vouch for you as being special/good at something specific.

6. If you can’t present yourself as a standout, be sure to really make a strong positive impression on someone who can send a personal and specific reference for you. That person needs to be connected to the people you want to meet.

View full thread

…but as a calling card when you want to get someone’s attention to maybe work with them. They will see from your map or article that you aren’t just a passive job seeker… you stand out as having done the extra work and might be worth their time.

5. Present yourself well. Use all the above to present an interesting and detailed story that shows who you are by what you have done and do. Don’t just tell people about your attributes (hard worker, creative, problem solver, etc)… that’s typically generic and boring. Never be boring.

View full thread

So make sure that you can speak specifically what you actually did (not same as claiming you did everything on your own… speak specifically about what every member of a team did). The people looking for doers recognize fellow doers by the specificity of their discussion of what they did.

4. Stand out by teaching what you know. Put in the hours to get expert at something. Map out an area of career interest (eg robots for elder care, AI-enabled drug discovery, market failures in medicines) that will serve not only to help you learn more about your area of interest…

View full thread

The world advances because of the people who get things done, but it’s often hard to know who those people are because so many people, at best, talk a big game and claim to have been involved in this or that accomplishment…

View full thread

3. Most importantly, rack up clear accomplishments… show what you DID, not just who you met or what you joined. That includes standing out during the NPLB fellowship and getting invited to be a Sr. Fellow and completing a project; those are accomplishments.

View full thread

2. Work AI into everything you do because it will transform your field. Especially if you think about a career in drug discovery or patient care, in 5-10 years you won’t recognize these fields because of how much AI will change them.

View full thread

Later, Richard Aldrich (where RA of RA Capital comes from) hired me because, sure, I knew some science, but more importantly I was proactive in learning what I didn’t know and he could trust that I wouldn’t sap his time by needing to be managed; he knew I would figure things out.

Peter Kolchinsky reposted

Love my bookshop; take my kids there to buy books b/c great experience. If it weren’t, I wouldn’t support just to keep them employed. Amazon is great, too (covid!). Even if it displaced bookshops, people would do something else society valued. Imagine shunning cars to support carriage drivers.

Amy Stuber@amystuber.com

don't order books (or anything) from Amazon today! Instead, order from a small press, Bookshop, a local bookstore, or request a book from your local library. Yes, Amazon is "easy," but it's continuing to kill local businesses and concentrate wealth.

You are up to date.